Search Results - R. Gorelick
- Showing 1 - 7 results of 7
-
1
PP 3.16 - 00209 Prolonged persistence of HIV-infected cells in tissues after allogeneic hematopoietic transplant by F. Maldarelli, T. Nguyen, L. Adams, M. Zipparo, R. Gorelick, S. Hewitt, S. Rajan, P. Rubinstein, J. Kanakry
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Clones of HIV-infected cells are widely distributed in T cell subsets in blood and in anatomic tissues by F. Maldarelli, M. Gozoulis, X. Wu, L. Perez, R. Gorelick, C. Lange, S. Hill, J. Virga, T. Uldrick, R. Yarchoan, S. Hughes
Published 2019Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
P 4.2 - 00029 Innate Immune Correlates of Cell-Associated HIV RNA And DNA During Long-Term Suppressive ART by C.-Y. Lau, R. Gorelick, J. Earhart, J. Higgins, R. Dewar, D. McMahon, A. Ganesan, B. Luke, F. Maldarelli
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
4
OA2-5 LB No evidence of ongoing replication in tissue compartments during combination antiretroviral therapy by G. Bozzi, S. Watters, F.R. Simonetti, E. Anderson, R. Gorelick, W. Shao, J. Bell, C. Rehm, R. Dewar, R. Yarchoan, T. Uldrick, F. Maldarelli
Published 2016Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
5
35 Therapy with the immunomodulatory agent pomalidomide does not lead to changes in HIV-1 viral populations in vivo by S.A. Watters, M.N. Polizzotto, W. Shao, R. Gorelick, E.M. Anderson, I. Sereti, K. Aleman, L. Kouyoudjian, J.B. Zeldis, T. Uldrick, R. Yarchoan, F. Maldarelli
Published 2016Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
6
Blinded evaluation of ultrasensitive assays of HIV in plasma by S.M. Keating, M. Stone, X. Deng, J. Mellors, S. Bakkour, D. Richman, R. Gorelick, J. Lifson, C. Jennings, M. Stengelin, G. Wu, B.J. Howell, P. Bacchetti, M.P. Busch
Published 2017Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
7
Interim safety analysis of cancer immunotherapy trials Network - 12 (CITN-12): a Phase 1 study of pembrolizumab in patients with HIV and cancer by T.S. Uldrick, M.A. 'Mac' Cheever, P.H. Gonçalves, S. Fling, K. Aleman, B. Emu, M.S. Ernstoff, R. Gorelick, J. Kaiser, H. E Kohrt, A. Lacroix, M. Lindsley, L. M Lundgren, K. Lurain, F. Maldarelli, C. Parsons, E. Sharon, A. Widell, R. Yarchoan
Published 2017Call Number: Loading…Connect to this object online.
Located: Loading…
Book